Which of the following statements about addiction treatment medications is true?

Buprenorphine is a partial opioid agonist that is recognized for its efficacy in treating opioid use disorder. It works by attaching to the same receptors in the brain as other opioids but activates them less intensely, which helps reduce cravings and withdrawal symptoms. This characteristic makes buprenorphine a suitable medication for individuals seeking to manage their opioid addiction, as it can aid in stabilizing their condition while also reducing the risk of misuse associated with full agonists like methadone or heroin.

In contrast, methadone specifically has restrictions regarding its prescription. It is typically dispensed only through specially licensed treatment programs. Also, buprenorphine cannot be dispensed without a prescription, as it is classified as a controlled substance that requires a healthcare provider's oversight. Lastly, the assertion that patients cannot receive medication without prior counseling does not align with current practices, as buprenorphine can be initiated in a medication-first approach, following guidelines that can include counseling later in the treatment process. Therefore, buprenorphine's recognized role in opioid addiction treatment affirms the truth of the selected statement.